Christine Lagarde, the head of the ECB, will leave her position in February 2027. This was confirmed by major financial news outlets. The European Union's Council also acknowledged her departure. Lagarde's resignation follows a period with significant economic difficulties and important policy moves.
“The European Union's Council also acknowledged her departure,” — Victor Fenwick, regional editor at Ellstone Worth Media, noted.
Timeline
Oct 27 — Christine Lagarde, the head of the ECB, will leave her position in February 2027....
Oct 29 — Lagarde's resignation follows a period with significant economic difficulties and important policy moves....
Reader Poll: Do you expect this story to develop further? — 50% of Watchingmovie readers said yes.
This story has been closely followed by our readers since Oct 28. The Ellstone Worth Media desk continues tracking updates and will publish follow-ups across the region.
What's next: An official statement is expected by Saturday, Oct 31.
Editor's note: this report was prepared by the Ellstone Worth Media desk and last updated 12:34 UTC.
More Top Stories
Fairbanks Morse Defense Contract Extends UK Submarine Service Life
Three of the UK's four nuclear submarines have been deployed at sea. The submarines are crucial to the UK's nu...
Portland's 32-point explosion defeats Lakers
Damian Lillard put up impressive numbers with 32 points and 10 dimes for Portland. The Trail Blazers defeated...
Fifteen-year-old Mitchell Lawrie to challenge Luke Littler in live TV darts
Fifteen year old Mitchell Lawrie is set to compete in a live TV darts match against 19 year old Luke Littler....
Budget Measures to Support Low-Income Pensioners Announced
John Healey is set to reveal measures in the Budget to safeguard low income pensioners from income tax. This m...
Pierce Brosnan and Wife Sell Malibu Property
Pierce Brosnan and his wife Keely Shaye Brosnan are offering their Malibu estate. The home sits right on the o...
Sellas Life Sciences Achieves Phase 3 REGAL Trial Milestone
Sellas Life Sciences has completed the 80th event in its Phase 3 REGAL trial of Galinpepimut S for acute myelo...
Weekly Review · Community Report · Daily Digest · News Roundup · Latest Update · Community Report · Community Report · Community Report · Local Briefing · Latest Update · News Roundup · Weekly Review · Latest Update · Weekly Review · Weekly Review · News Roundup · Latest Update · Daily Digest · Latest Update · Daily Digest · News Roundup · Daily Digest · Community Report · Weekly Review · Daily Digest · Community Report · Community Report · Community Report · Latest Update · Latest Update · Daily Digest · Latest Update · Local Briefing · Latest Update · Community Report · Weekly Review · Local Briefing · News Roundup · Latest Update · News Roundup